SIRPA, BTN3A1, and TDO2 in osteosarcoma: a prognostic triad with therapeutic implications from integrated genomic and pharmacogenomic data
Abstract The limited understanding of the prognostic implications of immune checkpoint molecules in osteosarcoma (OS) poses significant challenges for improving patient outcomes. There is a gap in the identification of reliable biomarkers that can predict treatment response and prognosis in OS patie...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-08-01
|
| Серии: | Journal of Orthopaedic Surgery and Research |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s13018-025-06171-7 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|